[Federal Register Volume 84, Number 28 (Monday, February 11, 2019)]
[Notices]
[Pages 3191-3192]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01812]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA-2012-N-0438; FDA-2018-D-1592; FDA-2014-D-2138; FDA-
2018-N-0180; FDA-2014-N-1960; FDA-2015-N-1837; and FDA-2016-D-4308]
Agency Information Collection Activities; Announcement of Office
of Management and Budget Approvals
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is publishing a list of
information collections that have been approved by the Office of
Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations,
Food and Drug Administration, Three White Flint North, 10A-12M, 11601
Landsdown St., North Bethesda, MD 20852, 301-796-7726,
[email protected].
SUPPLEMENTARY INFORMATION: The following is a list of FDA information
collections recently approved by OMB under section 3507 of the
Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control
number and expiration date of OMB approval for each information
collection are shown in table 1. Copies of the supporting statements
for the information collections are available on the internet at
https://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or
sponsor, and a person is not required to respond to, a collection of
[[Page 3192]]
information unless it displays a currently valid OMB control number.
Table 1--List of Information Collections Approved by OMB
------------------------------------------------------------------------
OMB Control Date approval
Title of collection No. expires
------------------------------------------------------------------------
Recommendations for Early Food Safety 0910-0583 10/31/2021
Evaluation of New Non-Pesticidal
Proteins Produced by New Plant
Varieties Intended for Food Use........
Guidance for Industry on Controlled 0910-0797 10/31/2021
Correspondence Related to Generic Drug
Development............................
Guidance for Industry on Adverse Event 0910-0800 10/31/2021
Reporting for Outsourcing Facilities
Under Section 503B of the Federal Food,
Drug, and Cosmetic Act.................
Generic Clearance for the Collection of 0910-0810 10/31/2021
Quantitative Data on Tobacco Products
and Communications.....................
MedWatch: Adverse Event and Product 0910-0291 11/30/2021
Experience Reporting System (Paper-
Based).................................
Electronic User Fee Payment Form 0910-0805 11/30/2021
Requests...............................
Labeling of Red Blood Cell Units with 0910-0862 11/30/2021
Historical Antigen Typing Results......
Postmarketing Adverse Drug Experience 0910-0230 12/31/2021
Reporting..............................
------------------------------------------------------------------------
Dated: February 5, 2019.
Lowell J. Schiller,
Acting Associate Commissioner for Policy.
[FR Doc. 2019-01812 Filed 2-8-19; 8:45 am]
BILLING CODE 4164-01-P